Mangalam Drugs And Organics Limited (MANGALAM) — Stock Analysis

Mangalam Drugs And Organics Limited (NSE: MANGALAM), ISIN INE584F01014 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.

MANGALAM last traded at ₹26.96 (-1.10%), with a 52-week range of ₹22.70 to ₹90.67 (as of 30 Jul 2026).

Shareholding as of Mar 2026: promoters 35.65%, FIIs 0.32%, DIIs 0.00%, mutual funds 0.00%.

EquiSense Score (ECS): 68/100.

Data sourced from NSE and BSE filings. Educational — not investment advice.